Product NDC 76420-0949

7 indexed presentations under this Product NDC family.

Reference only for licensed healthcare facilities. These listings support exact-NDC identification and quote review, and do not imply current stock, manufacturer sponsorship, or direct purchasing status. Review package-specific NDC rows, compare configurations, and request a quote review when needed.

Need a Product Not Listed?

Submit a quote review for unlisted NDCs, item codes, or alternate product presentations.

Request a Quote Review

Drug Catalog Search | Request a Quote Review

Family context

Product NDC 76420-0949 groups closely related presentations under the same catalog family, giving healthcare teams a clearer path for comparing packaging and alternate exact NDC rows before a quote review is requested.

Family size: 7 indexed presentations.
Generic family: Ondansetron.
Primary dosage form: Tablet.
Common strength: 8 mg / 1.

What changes inside this family

Use the family page to compare formats, then click into the exact NDC page that matches the package your team needs.

Manufacturers shown: Asclemed Usa Inc..
Dosage forms shown: Tablet.
Package quantities: 10 Tablet, Orally Disintegrating, 100 Tablet, Orally Disintegrating, 20 Tablet, Orally Disintegrating, 3 Blister Pack, and 30 Tablet, Orally Disintegrating.

Manufacturer identifiers

Manufacturer information is shown for product identification only.

Asclemed Usa Inc.

Exact-item pages in this family

Ondansetron 8 mg / 1 Tablet 10 Tablet, Orally DisintegratingNDC 76420-0949-10 | 10 Tablet, Orally Disintegrating | Asclemed Usa Inc.

Ondansetron 8 mg / 1 Tablet 100 Tablet, Orally DisintegratingNDC 76420-0949-01 | 100 Tablet, Orally Disintegrating | Asclemed Usa Inc.

Ondansetron 8 mg / 1 Tablet 20 Tablet, Orally DisintegratingNDC 76420-0949-20 | 20 Tablet, Orally Disintegrating | Asclemed Usa Inc.

Ondansetron 8 mg / 1 Tablet 3 Blister PackNDC 76420-0949-33 | 3 Blister Pack | Asclemed Usa Inc.

Ondansetron 8 mg / 1 Tablet 30 Tablet, Orally DisintegratingNDC 76420-0949-30 | 30 Tablet, Orally Disintegrating | Asclemed Usa Inc.

Ondansetron 8 mg / 1 Tablet 60 Tablet, Orally DisintegratingNDC 76420-0949-60 | 60 Tablet, Orally Disintegrating | Asclemed Usa Inc.

Official family references

Use official family-level references to verify labeling context while comparing the child NDC presentations shown on this page.

Search DailyMed labelingOpens DailyMed search results.

Showing page 1 of 1


Ondansetron 8 mg / 1 Tablet 10 Tablet, Orally Disintegrating	76420-0949-10	8 mg / 1	Tablet	10 Tablet, Orally Disintegrating
Ondansetron 8 mg / 1 Tablet 100 Tablet, Orally Disintegrating	76420-0949-01	8 mg / 1	Tablet	100 Tablet, Orally Disintegrating
Ondansetron 8 mg / 1 Tablet 20 Tablet, Orally Disintegrating	76420-0949-20	8 mg / 1	Tablet	20 Tablet, Orally Disintegrating
Ondansetron 8 mg / 1 Tablet 3 Blister Pack	76420-0949-33	8 mg / 1	Tablet	3 Blister Pack
Ondansetron 8 mg / 1 Tablet 30 Tablet, Orally Disintegrating	76420-0949-30	8 mg / 1	Tablet	30 Tablet, Orally Disintegrating
Ondansetron 8 mg / 1 Tablet 60 Tablet, Orally Disintegrating	76420-0949-60	8 mg / 1	Tablet	60 Tablet, Orally Disintegrating
Ondansetron 8 mg / 1 Tablet 90 Tablet, Orally Disintegrating	76420-0949-90	8 mg / 1	Tablet	90 Tablet, Orally Disintegrating

Page 1 of 1

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.